Reg FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 24, 2026 ___________________________________ The Procter & Gamble Company (Exact name of registrant as specified in its charter) ___________________________________ Ohio (State or other jurisdiction of incorporation or organization) 001-00434 (Commission File Number) 31-0411980 (I.R.S. Employer Identification Number) One Procter & Gamble Plaza Cincinnati , Ohio 45202 (Address of principal executive offices and zip code) ( 513 ) 983-1100 (Registrant's telephone number, including area code) ___________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock without Par Value PG NYSE 0.110% Notes due 2026 PG26D NYSE 3.25% EUR Notes due 2026 PG26F NYSE 4.875% EUR Notes due May 2027 PG27A NYSE 1.200% Notes due 2028 PG28 NYSE 3.150% EUR Notes due 2028 PG28B NYSE 1.250% Notes due 2029 PG29B NYSE 1.800% Notes due 2029 PG29A NYSE 6.250% GBP Notes due January 2030 PG30 NYSE 0.350% Notes due 2030 PG30C NYSE 0.230% Notes due 2031 PG31A NYSE 3.250% EUR Notes due 2031 PG31B NYSE 5.250% GBP Notes due January 2033 PG33 NYSE 2.900% EUR Notes due 2033 PG33B NYSE 3.200% EUR Notes due 2034 PG34C NYSE 1.875% Notes due 2038 PG38 NYSE 0.900% Notes due 2041 PG41 NYSE 3.650% Notes due 2045 PG45 NYSE Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act. Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01 - Regulation FD Disclosure On April 24, 2026, The Procter & Gamble Company (the "Company") issued a press release announcing its third quarter results and hosted a conference call related to those results. The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure." Item 9.01 - Financial Statements and Exhibits (d): The following exhibits are being filed herewith: Exhibit No. Description 99.1 Informational Slides Provided by The Procter & Gamble Company dated April 24, 2026. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 24th day of April, 2026. THE PROCTER & GAMBLE COMPANY By: /s/ Sandra T. Lane Name: Sandra T. Lane Title: Assistant Secretary INDEX TO EXHIBIT(S) 99.1 - Informational Slides Provided by The Procter & Gamble Company dated April 24, 2026 .